Somatic BRCA Mutation in a Cholangiocarcinoma Patient for HBOC Syndrome Detection

BRCA-associated hereditary breast and ovarian cancer syndrome (HBOC) is characterized by an increased risk of developing other malignancies including cholangiocarcinoma (CCA). Somatic BRCA mutations have been reported in CCA, but they have yet to be utilized in a proband case to identify HBOC in fam...

Full description

Bibliographic Details
Main Authors: Angelo Virgilio Paradiso, Margherita Patruno, Maria Digennaro, Stefania Tommasi, Brunella Pilato, Antonella Argentiero, Oronzo Brunetti, Nicola Silvestris
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-08-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.01292/full
_version_ 1818960193807974400
author Angelo Virgilio Paradiso
Angelo Virgilio Paradiso
Margherita Patruno
Maria Digennaro
Stefania Tommasi
Brunella Pilato
Antonella Argentiero
Oronzo Brunetti
Nicola Silvestris
Nicola Silvestris
author_facet Angelo Virgilio Paradiso
Angelo Virgilio Paradiso
Margherita Patruno
Maria Digennaro
Stefania Tommasi
Brunella Pilato
Antonella Argentiero
Oronzo Brunetti
Nicola Silvestris
Nicola Silvestris
author_sort Angelo Virgilio Paradiso
collection DOAJ
description BRCA-associated hereditary breast and ovarian cancer syndrome (HBOC) is characterized by an increased risk of developing other malignancies including cholangiocarcinoma (CCA). Somatic BRCA mutations have been reported in CCA, but they have yet to be utilized in a proband case to identify HBOC in families. Two healthy daughters of a deceased female patient who had had metachronous breast cancer and CCA received genetic counseling to assess their cancer risk. Somatic BRCA1/2 mutation analysis was performed by next-generation sequencing on the DNA extracted from a formalin-fixed, paraffin-embedded CCA biopsy specimen of their mother. A pathogenic variant was identified (c.6468_6469delTC in a BRCA2 gene mutation). Germline BRCA mutation analysis of the two daughters detected the same pathogenic variant in one of them. For the first time, a CCA somatic BRCA mutation has been used to identify a family with HBOC.
first_indexed 2024-12-20T11:53:39Z
format Article
id doaj.art-13dd6537fc884920a7dd17e31fc8bd64
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-12-20T11:53:39Z
publishDate 2020-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-13dd6537fc884920a7dd17e31fc8bd642022-12-21T19:41:42ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2020-08-011010.3389/fonc.2020.01292539092Somatic BRCA Mutation in a Cholangiocarcinoma Patient for HBOC Syndrome DetectionAngelo Virgilio Paradiso0Angelo Virgilio Paradiso1Margherita Patruno2Maria Digennaro3Stefania Tommasi4Brunella Pilato5Antonella Argentiero6Oronzo Brunetti7Nicola Silvestris8Nicola Silvestris9Experimental Oncology—Center for the Study of Hereditary Cancers, IRCCS-Istituto Tumori “Giovanni Paolo II”, Bari, ItalyScientific Direction, IRCCS-Istituto Tumori “Giovanni Paolo II”, Bari, ItalyExperimental Oncology—Center for the Study of Hereditary Cancers, IRCCS-Istituto Tumori “Giovanni Paolo II”, Bari, ItalyExperimental Oncology—Center for the Study of Hereditary Cancers, IRCCS-Istituto Tumori “Giovanni Paolo II”, Bari, ItalyMolecular and Pharmacogenetics Diagnostic Laboratory, IRCCS-Istituto Tumori “Giovanni Paolo II”, Bari, ItalyMolecular and Pharmacogenetics Diagnostic Laboratory, IRCCS-Istituto Tumori “Giovanni Paolo II”, Bari, ItalyMedical Oncology Unit, IRCCS-Istituto Tumori “Giovanni Paolo II”, Bari, ItalyMedical Oncology Unit, IRCCS-Istituto Tumori “Giovanni Paolo II”, Bari, ItalyMedical Oncology Unit, IRCCS-Istituto Tumori “Giovanni Paolo II”, Bari, ItalyDepartment of Biomedical Sciences and Human Oncology, University of Bari “Aldo Moro”, Bari, ItalyBRCA-associated hereditary breast and ovarian cancer syndrome (HBOC) is characterized by an increased risk of developing other malignancies including cholangiocarcinoma (CCA). Somatic BRCA mutations have been reported in CCA, but they have yet to be utilized in a proband case to identify HBOC in families. Two healthy daughters of a deceased female patient who had had metachronous breast cancer and CCA received genetic counseling to assess their cancer risk. Somatic BRCA1/2 mutation analysis was performed by next-generation sequencing on the DNA extracted from a formalin-fixed, paraffin-embedded CCA biopsy specimen of their mother. A pathogenic variant was identified (c.6468_6469delTC in a BRCA2 gene mutation). Germline BRCA mutation analysis of the two daughters detected the same pathogenic variant in one of them. For the first time, a CCA somatic BRCA mutation has been used to identify a family with HBOC.https://www.frontiersin.org/article/10.3389/fonc.2020.01292/fullBRCA1BRCA2biliary tract cancershereditary BRCA cancersomatic mutations
spellingShingle Angelo Virgilio Paradiso
Angelo Virgilio Paradiso
Margherita Patruno
Maria Digennaro
Stefania Tommasi
Brunella Pilato
Antonella Argentiero
Oronzo Brunetti
Nicola Silvestris
Nicola Silvestris
Somatic BRCA Mutation in a Cholangiocarcinoma Patient for HBOC Syndrome Detection
Frontiers in Oncology
BRCA1
BRCA2
biliary tract cancers
hereditary BRCA cancer
somatic mutations
title Somatic BRCA Mutation in a Cholangiocarcinoma Patient for HBOC Syndrome Detection
title_full Somatic BRCA Mutation in a Cholangiocarcinoma Patient for HBOC Syndrome Detection
title_fullStr Somatic BRCA Mutation in a Cholangiocarcinoma Patient for HBOC Syndrome Detection
title_full_unstemmed Somatic BRCA Mutation in a Cholangiocarcinoma Patient for HBOC Syndrome Detection
title_short Somatic BRCA Mutation in a Cholangiocarcinoma Patient for HBOC Syndrome Detection
title_sort somatic brca mutation in a cholangiocarcinoma patient for hboc syndrome detection
topic BRCA1
BRCA2
biliary tract cancers
hereditary BRCA cancer
somatic mutations
url https://www.frontiersin.org/article/10.3389/fonc.2020.01292/full
work_keys_str_mv AT angelovirgilioparadiso somaticbrcamutationinacholangiocarcinomapatientforhbocsyndromedetection
AT angelovirgilioparadiso somaticbrcamutationinacholangiocarcinomapatientforhbocsyndromedetection
AT margheritapatruno somaticbrcamutationinacholangiocarcinomapatientforhbocsyndromedetection
AT mariadigennaro somaticbrcamutationinacholangiocarcinomapatientforhbocsyndromedetection
AT stefaniatommasi somaticbrcamutationinacholangiocarcinomapatientforhbocsyndromedetection
AT brunellapilato somaticbrcamutationinacholangiocarcinomapatientforhbocsyndromedetection
AT antonellaargentiero somaticbrcamutationinacholangiocarcinomapatientforhbocsyndromedetection
AT oronzobrunetti somaticbrcamutationinacholangiocarcinomapatientforhbocsyndromedetection
AT nicolasilvestris somaticbrcamutationinacholangiocarcinomapatientforhbocsyndromedetection
AT nicolasilvestris somaticbrcamutationinacholangiocarcinomapatientforhbocsyndromedetection